BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28458073)

  • 1. Community-directed mass drug administration is undermined by status seeking in friendship networks and inadequate trust in health advice networks.
    Chami GF; Kontoleon AA; Bulte E; Fenwick A; Kabatereine NB; Tukahebwa EM; Dunne DW
    Soc Sci Med; 2017 Jun; 183():37-47. PubMed ID: 28458073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda.
    Chami GF; Kabatereine NB; Tukahebwa EM
    BMC Med; 2019 Mar; 17(1):69. PubMed ID: 30917824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The division of labour between community medicine distributors influences the reach of mass drug administration: A cross-sectional study in rural Uganda.
    Chami GF; Kabatereine NB; Tukahebwa EM
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007685. PubMed ID: 31483784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda.
    Chami GF; Kontoleon AA; Bulte E; Fenwick A; Kabatereine NB; Tukahebwa EM; Dunne DW
    Clin Infect Dis; 2016 Jan; 62(2):200-7. PubMed ID: 26409064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social network fragmentation and community health.
    Chami GF; Ahnert SE; Kabatereine NB; Tukahebwa EM
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7425-E7431. PubMed ID: 28739906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion of treatment in social networks and mass drug administration.
    Chami GF; Kontoleon AA; Bulte E; Fenwick A; Kabatereine NB; Tukahebwa EM; Dunne DW
    Nat Commun; 2017 Dec; 8(1):1929. PubMed ID: 29208898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of therapeutic coverage of mass treatment campaign against lymphatic filariasis in two health districts in Burkina Faso].
    Serme M; Zida A; Bougma R; Kima A; Nassa C; Ouedraogo M; Kabre C; Zoromé H; Guire I; Nare D; Bougouma C
    Med Trop Sante Int; 2022 Dec; 2(4):. PubMed ID: 36815181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
    Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone.
    Kamara W; Zoerhoff KL; Toubali EH; Hodges MH; Bisanzio D; Chowdhury D; Sonnie M; Magbity E; Samai M; Conteh A; Macarthy F; Baker M; Koroma JB
    PLoS One; 2019; 14(12):e0224422. PubMed ID: 31856176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
    Anto F; Asoala V; Anyorigiya T; Oduro A; Adjuik M; Akweongo P; Aborigo R; Bimi L; Amankwa J; Hodgson A
    Trop Med Int Health; 2011 Sep; 16(9):1112-9. PubMed ID: 21689221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Praziquantel Treatment Coverage for
    Adriko M; Faust CL; Carruthers LV; Moses A; Tukahebwa EM; Lamberton PHL
    Trop Med Infect Dis; 2018 Oct; 3(4):. PubMed ID: 30297642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
    Njomo DW; Kimani BW; Kibe LW; Okoyo C; Omondi WP; Sultani HM
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0009012. PubMed ID: 33370300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage evaluation of mass drug administration with triple drug regimen in an evaluation unit in Nagpur district of Maharashtra, India.
    Dinesh RJ; Srividya A; Subramanian S; Krishnamoorthy K; Sabesan S; Raghorte MC; Kumar A; Jambulingam P
    PLoS Negl Trop Dis; 2023 Sep; 17(9):e0011588. PubMed ID: 37676897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis.
    Budge PJ; Sognikin E; Akosa A; Mathieu EM; Deming M
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004358. PubMed ID: 26766287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing population-based mass drug administration for malaria: experience from a high transmission setting in North Eastern Uganda.
    Mulebeke R; Wanzira H; Bukenya F; Eganyu T; Collborn K; Elliot R; Van Geertruyden JP; Echodu D; Yeka A
    Malar J; 2019 Aug; 18(1):271. PubMed ID: 31399051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana.
    Dicko I; Coulibaly YI; Sangaré M; Sarfo B; Nortey PA
    Infect Disord Drug Targets; 2020; 20(2):167-174. PubMed ID: 30727921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proxy Responses for Mass Drug Administration Coverage Surveys: The Trends and Biases When Others are Allowed to Respond.
    Jose R; Bougma R; Drabo F; Tukahebwa EM; Mkwanda S; Gass K
    Am J Trop Med Hyg; 2021 Oct; 106(1):268-274. PubMed ID: 34695783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious limitations of the current strategy to control Soil-Transmitted Helminths and added value of Ivermectin/Albendazole mass administration: A population-based observational study in Cameroon.
    Djune-Yemeli L; Nana-Djeunga HC; Lenou-Nanga CG; Donfo-Azafack C; Domche A; Fossuo-Thotchum F; Niamsi-Emalio Y; Ntoumi F; Kamgno J
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008794. PubMed ID: 33141853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of triple drug administration (TDA) with praziquantel, ivermectin and albendazole for the prevention of neglected tropical diseases in Nigeria.
    Evans D; McFarland D; Adamani W; Eigege A; Miri E; Schulz J; Pede E; Umbugadu C; Ogbu-Pearse P; Richards FO
    Ann Trop Med Parasitol; 2011 Dec; 105(8):537-47. PubMed ID: 22325813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.